Literature DB >> 16503147

Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.

M R Chacón1, C Richart, J M Gómez, A Megía, N Vilarrasa, J M Fernández-Real, A García-España, M Miranda, C Masdevall, W Ricard, E Caubet, J Soler, J Vendrell.   

Abstract

TWEAK, a cytokine of the TNF family, has been found to be expressed under different inflammatory conditions but no data is available concerning the expression of this cytokine and its receptor (Fn14) in human obesity. In the present work we have evaluated the expression of many pro-inflammatory TNF system cytokines (TNF-alpha, TWEAK and their respective receptors, TNFR1, TNFR2 and Fn14) in human adipose tissue of 84 subjects some with different degree of obesity and type 2 diabetes, and its relation with inflammation by also measuring the expression of macrophage marker CD68. We detected expression of TWEAK and Fn14 in isolated mature adipocytes and in the stromovascular fraction. Additionally, we found that LPS upregulates the expression of both genes on THP-1 human monocytic cell line. TWEAK was expressed in adipose tissue of all studied subjects with no differences between obesity group, and was associated with Fn14 expression in morbid obese, mainly in women with type 2 diabetes. The data obtained here also showed that TNF-alpha and TNFR2 mRNAs were significantly more expressed in subcutaneous adipose tissue of subjects with morbid obesity compared to obese and non-obese subjects. In contrast, TNFR1 gene expression was negatively associated with BMI. Our results suggest that the expression of TNF-derived pro-inflammatory cytokines are increased in severe obesity, where macrophage infiltrate could modulate the inflammatory environment through activation of its receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503147     DOI: 10.1016/j.cyto.2005.12.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  26 in total

1.  Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer.

Authors:  Cemil Bilir; Huseyin Engin; Murat Can; Sevili Likhan; Derya Demirtas; Fatih Kuzu; Taner Bayraktaroglu
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

2.  Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions.

Authors:  Perla Abigail Alvarado-Vazquez; Laura Bernal; Candler A Paige; Rachel L Grosick; Carolina Moracho Vilrriales; David Wilson Ferreira; Cristina Ulecia-Morón; E Alfonso Romero-Sandoval
Journal:  Immunobiology       Date:  2017-05-16       Impact factor: 3.144

3.  Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.

Authors:  Shuichi Sato; Yuji Ogura; Marjan M Tajrishi; Ashok Kumar
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 4.  Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes.

Authors:  Fangnian Wang; Jude T Deeney; Gerald V Denis
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

5.  Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.

Authors:  J Lozano-Bartolomé; G Llauradó; M M Rodriguez; J M Fernandez-Real; J F Garcia-Fontgivell; J Puig; E Maymó-Masip; J Vendrell; M R Chacón
Journal:  Int J Obes (Lond)       Date:  2016-04-28       Impact factor: 5.095

Review 6.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 7.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

8.  Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans.

Authors:  Frederic Reynier; Alex F de Vos; Jacobien J Hoogerwerf; Paul Bresser; Jaring S van der Zee; Malick Paye; Alexandre Pachot; Bruno Mougin; Tom van der Poll
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

Review 9.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

10.  Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.

Authors:  Debra T Chao; Mian Su; Sonia Tanlimco; Mien Sho; Donghee Choi; Mel Fox; Shiming Ye; Eric D Hsi; Lisa Durkin; Johnny Yin; Yongke Zhang; Han Kim; Gary C Starling; Patricia A Culp
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-17       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.